Life Laboratories had difficulty meeting low-end sensitivity for HCV viral load testing needed for new drug therapies and were facing physician discontent around resulting delays. They also were using multiple molecular instrument platforms with inconsistent reliability.
By partnering with Abbott and choosing the m2000 RealTime System, Life Laboratories saw measurable results in cost savings, improved test completion time, and improved physician satisfaction.
Life Labs realized several benefits with their new solution, including enhanced processing, more staff trained, and better instrument reliability.
Throughout the process, Abbott closely partnered with Life Laboratories to examine current workflow operations, make solution recommendations, and measure results after implementation of the m2000 RealTime System.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.